Drug Name | IUPAC Name | Classification (KD Tripathi) | Drug Application | Receptors | Dosage Form | Route of Administration | Adverse Reactions | Appearance | Solubility | pKa Value | Functional Groups |
---|---|---|---|---|---|---|---|---|---|---|---|
Atenolol | (2S)-1-(4-hydroxy-3-(1-methylethyl)phenyl)propan-2-ol | Beta-blocker Subclass: Selective beta-1-adrenergic antagonist |
Hypertension, angina, arrhythmias | β1 adrenergic receptor | Tablet (25 mg, 50 mg, 100 mg) | Oral | Bradycardia, dizziness, fatigue | White crystalline powder | Slightly soluble in water | pKa = 9.6 | Phenol, alcohol |
Ramipril | 2-[1-(Ethoxycarbonyl)butyl]aprotinin | ACE inhibitor Subclass: Angiotensin-converting enzyme inhibitor |
Hypertension, heart failure | Angiotensin-converting enzyme (ACE) | Tablet (1.25 mg, 2.5 mg, 5 mg, 10 mg) | Oral | Cough, hyperkalemia, hypotension | White crystalline powder | Freely soluble in water | pKa = 3.9 | Carboxyl, amide |
Digoxin | 3β-Hydroxy-14β-hydroxy-5β,10β-dihydro-6β-oxopyrrolo[2,3-d]pyrimidine | Cardiac glycoside Subclass: Digitalis glycoside |
Heart failure, atrial fibrillation | Na+/K+ ATPase | Tablet (62.5 mcg, 125 mcg, 250 mcg) Injection (500 mcg/mL) |
Oral, Intravenous | Gastrointestinal upset, visual disturbances, arrhythmias | White to off-white crystalline powder | Slightly soluble in water | pKa = 4.0 | Steroid, lactone |
Simvastatin | (1S,3S,7S)-7-[2-(4-hydroxyphenyl)-3-methylbutyl]-1,2,3,7,8,8a-hexahydro-1,2,3,7,8,8a-hexahydroxy-1-naphthalenone | Statin Subclass: HMG-CoA reductase inhibitor |
Hyperlipidemia | HMG-CoA reductase | Tablet (5 mg, 10 mg, 20 mg, 40 mg, 80 mg) | Oral | Muscle pain, liver enzyme abnormalities, gastrointestinal symptoms | White crystalline powder | Practically insoluble in water | pKa = 5.5 | Phenol, lactone, hydroxy |
Nitroglycerin | 1,2,3-Propanetriol trinitrate | Nitrate Subclass: Organic nitrate |
Angina pectoris | Vascular smooth muscle | Tablet (0.3 mg, 0.6 mg, 0.9 mg) Transdermal patch (0.1 mg/hr, 0.2 mg/hr, 0.3 mg/hr) |
Oral, Transdermal, Intravenous | Headache, dizziness, hypotension | Colorless to pale yellow liquid | Slightly soluble in water | pKa = 3.1 | Nitrate ester, alcohol |
Lisinopril | (2S)-1-[(S)-[[2-[(1-carboxy-3-phenylpropyl)amino]carbonyl]amino]acetyl]amino]butan-2-ol | ACE inhibitor Subclass: Angiotensin-converting enzyme inhibitor |
Hypertension, heart failure | ACE | Tablet (2.5 mg, 5 mg, 10 mg, 20 mg) | Oral | Dizziness, headache, fatigue | White crystalline powder | Freely soluble in water | pKa = 3.9 | Carboxylic acid, amine |
Furosemide | 4-Chloro-2-[(furan-2-ylmethyl)amino]benzenesulfonamide | Diuretic Subclass: Loop diuretic |
Edema, hypertension | Na+/K+/2Cl- symporter | Tablet (20 mg, 40 mg, 80 mg) | Oral, Intravenous | Dehydration, electrolyte imbalance | White crystalline powder | Soluble in water | pKa = 3.9 | Aromatic amine, sulfonamide |
Losartan | 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazole-5-carboxylic acid | Angiotensin II receptor blocker Subclass: ARB |
Hypertension | Angiotensin II receptor | Tablet (25 mg, 50 mg, 100 mg) | Oral | Dizziness, hypotension | White crystalline powder | Soluble in water | pKa = 4.0 | Carboxylic acid, imidazole |
Clonidine | (2,6-Dichlorophenyl)N-methyl-2-imidazoline-2-amine | Alpha-2 agonist Subclass: Central alpha-2 adrenergic agonist |
Hypertension, ADHD | Alpha-2 adrenergic receptor | Tablet (0.1 mg, 0.2 mg) | Oral, Transdermal | Drowsiness, dry mouth | White crystalline powder | Soluble in water | pKa = 8.4 | Aromatic amine, imidazoline |
Diltiazem | (2S)-2-(4-(2-(2-(4-methoxyphenyl)thiazol-4-yl)ethyl)-2-methyl-1,3-thiazol-4-yl)ethyl)-2-methyl-1,3-thiazol-4-yl)acetamide | Calcium channel blocker Subclass: Benzothiazepine |
Hypertension, angina | L-type calcium channels | Capsule (30 mg, 60 mg, 120 mg) | Oral | Headache, dizziness, flushing | White crystalline powder | Soluble in water | pKa = 7.4 | Thiazepine, benzene |
Carvedilol | 2-[(2-methyl-3-(4-morpholinyl)phenyl)amino]-1-(4-hydroxyphenyl)propan-1-ol | Beta-blocker Subclass: Non-selective beta blocker |
Heart failure, hypertension | β1 and β2 adrenergic receptors | Tablet (3.125 mg, 6.25 mg, 12.5 mg, 25 mg) | Oral | Fatigue, dizziness | White to off-white powder | Slightly soluble in water | pKa = 9.5 | Aromatic amine, alcohol |
Atorvastatin | (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylamino)butyl]-3,5-dihydroxy-6-heptenoic acid | Statin Subclass: HMG-CoA reductase inhibitor |
Hyperlipidemia | HMG-CoA reductase | Tablet (10 mg, 20 mg, 40 mg, 80 mg) | Oral | Muscle pain, liver enzyme abnormalities | White crystalline powder | Poorly soluble in water | pKa = 4.5 | Phenol, acid |
Hydrochlorothiazide | 6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide | Diuretic Subclass: Thiazide diuretic |
Hypertension, edema | Na+/Cl- symporter | Tablet (12.5 mg, 25 mg, 50 mg) | Oral | Electrolyte imbalance, dehydration | White crystalline powder | Freely soluble in water | pKa = 7.0 | Sulfonamide, benzothiadiazine |
Propranolol | (S)-1-(1-naphthyloxy)-3-(isopropylamino)propan-2-ol | Beta-blocker Subclass: Non-selective beta blocker |
Hypertension, anxiety | β1 and β2 adrenergic receptors | Tablet (10 mg, 20 mg, 40 mg, 80 mg) | Oral | Fatigue, dizziness, bronchospasm | White crystalline powder | Soluble in water | pKa = 9.5 | Aromatic amine, alcohol |
Amiodarone | 2-butyl-3-(4-((2,4,6-tribromophenyl)ethynyl)phenyl)-2-propen-1-one | Antiarrhythmic Subclass: Class III |
Arrhythmias | K+ channels | Tablet (100 mg, 200 mg) | Oral | Pulmonary toxicity, thyroid dysfunction | White to off-white powder | Poorly soluble in water | pKa = 8.0 | Aromatic amine, alcohol |
Sotalol | (2S)-1-(4-[(1H-benzimidazol-2-yl)methyl]phenyl)propan-2-ol | Antiarrhythmic Subclass: Class III |
Arrhythmias | β adrenergic receptors | Tablet (80 mg, 120 mg) | Oral | Fatigue, bradycardia | White crystalline powder | Soluble in water | pKa = 9.2 | Alcohol |
Spironolactone | 17-hydroxy-3-oxopregn-4-ene-21-carboxylic acid | Diuretic Subclass: Potassium-sparing diuretic |
Heart failure, hypertension | Mineralocorticoid receptor | Tablet (25 mg, 50 mg, 100 mg) | Oral | Hyperkalemia, gynecomastia | White crystalline powder | Soluble in water | pKa = 5.9 | Steroid |
Nifedipine | (2E)-2,6-dimethyl-4-(2-nitrophenyl)-3-(pyridin-2-yl)-2-propenoic acid | Calcium channel blocker Subclass: Dihydropyridine |
Hypertension, angina | L-type calcium channels | Capsule (10 mg, 30 mg, 60 mg) | Oral | Flushing, headache, dizziness | Yellow crystalline powder | Slightly soluble in water | pKa = 5.4 | Carboxylic acid, nitrile |
Isosorbide dinitrate | 1,2-bis(nitrooxy)propane | Nitrate Subclass: Organic nitrate |
Angina pectoris | Vascular smooth muscle | Tablet (5 mg, 10 mg, 20 mg) | Oral | Headache, dizziness, hypotension | Colorless crystalline powder | Slightly soluble in water | pKa = 3.0 | Nitrate ester |
Amlodipine | (2S)-2-[(2-amino-4-methylphenyl)(2-chlorophenyl)methyl]-1,4-dihydro-6-methyl-3,5-pyridine-dicarboxylic acid | Calcium channel blocker Subclass: Dihydropyridine |
Hypertension, angina | L-type calcium channels | Tablet (2.5 mg, 5 mg, 10 mg) | Oral | Edema, flushing | White crystalline powder | Slightly soluble in water | pKa = 8.6 | Carboxylic acid, amine |
Nicardipine | (2E)-2,6-dimethyl-4-(2-nitrophenyl)-3-(pyridin-2-yl)-2-propenoic acid | Calcium channel blocker Subclass: Dihydropyridine |
Hypertension, angina | L-type calcium channels | Capsule (20 mg, 30 mg, 60 mg) | Oral | Headache, flushing, peripheral edema | White crystalline powder | Slightly soluble in water | pKa = 5.5 | Carboxylic acid, amine |
Verapamil | 2-(3-(4-(2-(3-hydroxy-3-phenylpropyl)phenyl)propyl)phenyl)propyl)phenyl}acetic acid | Calcium channel blocker Subclass: Phenylalkylamine |
Hypertension, angina | L-type calcium channels | Tablet (40 mg, 80 mg, 120 mg) | Oral, Intravenous | Constipation, dizziness | White crystalline powder | Slightly soluble in water | pKa = 8.4 | Aromatic amine, carboxylic acid |